Israel and New Zealand have provided interim approval for the sale of Nitric Oxide Nasal Spray (NONS) developed by SaNOtize Research and Development. The spray could help prevent the transmission of COVID-19 virus, stated the company.

Manufacturing of NONS has been started in Israel with SaNOtize’s partner Nextar Chempharma Solutions Ltd and the product is expected to be on sale this summer. Meanwhile, in New Zealand, the company has registered the spray with the New Zealand Medicines and Medical Devices Safety Authority. The company has been allowed there to distribute and sell the nasal spray over the counter immediately. New Zealand’s health ministry; however, clarified that the spray has not been approved for use as an anti-viral nasal spray… (Reuters, March 22, 2021)